Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P

Guagnini, F.; Valenti, M.; Mukenge, S.; Matias, I.; Bianchetti, A.; Di Palo, S.; Ferla, G.; Di Marzo, V.; Croci, I.
July 2006
Gut;Jul2006, Vol. 55 Issue 7, p946
Academic Journal
Background and aims: Diverticulosis is a common disease of not completely defined pathogenesis. Motor abnormalities of the intestinal wall have been frequently described but very little is known about their mechanisms. We investigated in vitro the neural response of colonic longitudinal muscle strips from patients undergoing surgery for complicated diverticular disease (diverticulitis). Methods: The neural contractile response to electrical field stimulation of longitudinal muscle strips from the colon of patients undergoing surgery for colonic cancer or diverticulitis was challenged by different receptor agonists and antagonists. Results: Contractions of colonic strips from healthy controls and diverticulitis specimens were abolished by atropine. The 13 adrenergic agonist (-) isoprenaline and the tachykinin NK1 receptor antagonist SR140333 had similar potency in reducing the electrical twitch response in controls and diseased tissues, while the cannabinoid receptor agonist (+)WIN 55,212-2 was 100 times more potent in inhibiting contractions in controls (IC50 42 nmol/l) than in diverticulitis strips. SR141716, a selective antagonist of the cannabinoid CB1 receptor, had no intrinsic activity in control preparations but potentiated the neural twitch in diseased tissues by up to 196% in a concentration dependent manner. SR141716 inhibited (+)WIN 55,212-2 induced relaxation in control strips but had no efficacy on (+)WIN 55,212-2 responses in strips from diverticular disease patients. Colonic levels of the endogenous ligand of cannabinoid and vanilloid TRPV1 receptors anandamide were more than twice those of control tissues (54 v 27 pmol/g tissue). The axonal conduction blocker tetrodotoxin had opposite effects in the two preparations, completely inhibiting the contractions of control strips but potentiating those in diverticular preparations, an effect selectively inhibited by SR140333. Conclusions: Neural control of colon motility is profoundly altered in patients with diverticulitis. Their raised levels of anandamide, apparent desensitisation of the presynaptic neural cannabinoid CB1 receptor, and the SR141716 induced intrinsic response, suggest that endocannabinoids may be involved in the pathophysiology of complications of colonic diverticular disease.


Related Articles

  • Enhanced recovery for patients following colorectal surgery. Burch, Jennie // Nursing Standard;9/12/2012, Vol. 27 Issue 2, p37 

    The gastrointestinal tract consists of different organs that may become diseased and require surgery. Colorectal surgery is commonly undertaken for conditions such as colorectal cancer and diverticular disease. This article discusses some of the more common operations to increase the reader's...

  • Erratum: The Risk of Inflammatory Bowel Disease-Related Colorectal Carcinoma Is Limited: Results From a Nationwide Nested Case-Control Study. Baars, Judith E; Looman, Caspar WN; Steyerberg, Ewout W; Beukers, Ruud; Tan, Adriaan CITL; Weusten, Bas LAM; Kuipers, Ernst J; van der Woude, Christien J // American Journal of Gastroenterology;May2014, Vol. 109 Issue 5, p781 

    A correction to the article "The Risk of Inflammatory Bowel Disease-Related Colorectal Carcinoma Is Limited: Results From a Nationwide Nested Case-Control Study" that was published in the May, 2014 issue is presented.

  • 5-Aminosalicylate is Not Protective From Neoplasia in Ulcerative Colitis. Bessissow, Talat; Bisschops, Raf; Ferrante, M; Baert, F; Van Assche, Gert; Rutgeerts, Paul; Vermeire, Severine // American Journal of Gastroenterology;Jun2013, Vol. 108 Issue 6, p1015 

    A letter to the editor is presented in response to the article "5-Aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations" by G. C. Nguyen in the 2012 issue.

  • Malignant Duodeno-Colic Fistula: A Rare Complication of Colorectal Cancer. GURAYA, SALMAN YOUSUF // Journal of Clinical & Diagnostic Research;Nov2015, Vol. 9 Issue 11, p1 

    A letter to the editor is presented in response to the article related to incidence of small bowel and colorectal cancer, published in a previous issue of 2015.

  • Meckel's Diverticulum. Martin, John P.; Connor, Pamela D.; Charles, Kerri // American Family Physician;2/15/2000, Vol. 61 Issue 4, p1037 

    Provides information on Meckel's diverticulum, most prevalent congenital abnormality of the gastrointestinal tract. Illustrative case of a woman; Incidence of the abnormality; Pathological association or conditions; Diagnosis; Complications.

  • EVENTS 2013/2014.  // Inflammatory Bowel Disease Monitor;2013, Vol. 14 Issue 1, p37 

    A calendar of events related to the digestive disease researches is presented from November 2013 to May 2014 which include the American Association for the Study of Liver Diseases meeting, the Advances in Inflammatory Bowel diseases, and the Turnbull International Colorectal Disease Symposium.

  • Corrigendum: 5-Aminosalicylic Acid Is Not Protective Against Colorectal Cancer in Inflammatory Bowel Disease: A Meta-Analysis of Non-Referral Populations. Nguyen, Geoffrey C; Gulamhusein, Aliya; Bernstein, Charles N // American Journal of Gastroenterology;Feb2013, Vol. 108 Issue 2, p292 

    A correction to the article "5-Aminosalicylic Acid Is Not Protective Against Colorectal Cancer in Inflammatory Bowel Disease: A Meta-Analysis of Non-Referral Populations" that was published in the previous issue is presented.

  • Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. J Tack // Gut;Mar2009, Vol. 58 Issue 3, p357 

    OBJECTIVE: To determine the efficacy, impact on quality of life (QOL) and safety of prucalopride, a selective, high-affinity 5-HT4receptor agonist, in patients with chronic constipation. METHODS: In this multicentre, randomised, placebo controlled, parallel-group, phase III study, patients with...

  • Familial Colonic Cancer Without Antecedent Polyposis. Boland, C. Richard; Troncale, Frank J. // Annals of Internal Medicine;May84, Vol. 100 Issue 5, p700 

    Presents a case study of a patient with familial colonic cancer without antecedent polyposis. Medical history of the patient; Results of physical examinations; Discussion of the condition.


Read the Article


Sign out of this library

Other Topics